Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Flow cytometry analysis of MSC markers at early and late passages

From: Oxidative status predicts quality in human mesenchymal stem cells

Surface Weak MSC Vigorous MSC
markers Early Late Early Late
CD14 99.4 ± 0.2 99.6 ± 0.1 99.5 ± 0.4 98.8 ± 0.3
CD44+ 100.0 ± 0.1 100.0 ± 0.2 99.7 ± 0.5 100.0 ± 0.1
CD90+ 83.4 ± 15.7 31.0 ± 21.6* 95.2 ± 3.8 57.3 ± 49.3
CD105+ 98.0 ± 1.7 98.7 ± 1.8 99.0 ± 0.8 99.5 ± 0.2
  1. Values are shown as mean % expression ± SD; n = 3 per group
  2. *p < 0.05 compared to early passages
  3. MSC mesenchymal stem cells